Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Crystal structure of the BMP-2-BRIA ectodomain complex.

Kirsch T, Sebald W, Dreyer MK.

Nat Struct Biol. 2000 Jun;7(6):492-6.

PMID:
10881198
2.

Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.

Hatta T, Konishi H, Katoh E, Natsume T, Ueno N, Kobayashi Y, Yamazaki T.

Biopolymers. 2000;55(5):399-406.

PMID:
11241215
3.

Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.

Kotzsch A, Nickel J, Seher A, Heinecke K, van Geersdaele L, Herrmann T, Sebald W, Mueller TD.

J Biol Chem. 2008 Feb 29;283(9):5876-87. Epub 2007 Dec 26.

4.

Molecular recognition of BMP-2 and BMP receptor IA.

Keller S, Nickel J, Zhang JL, Sebald W, Mueller TD.

Nat Struct Mol Biol. 2004 May;11(5):481-8. Epub 2004 Apr 4.

PMID:
15064755
5.

The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.

Nickel J, Dreyer MK, Kirsch T, Sebald W.

J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S7-14. Review.

PMID:
11263668
6.

Isolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP-2.

Kirsch T, Nickel J, Sebald W.

FEBS Lett. 2000 Feb 25;468(2-3):215-9.

7.

A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.

Namiki M, Akiyama S, Katagiri T, Suzuki A, Ueno N, Yamaji N, Rosen V, Wozney JM, Suda T.

J Biol Chem. 1997 Aug 29;272(35):22046-52.

8.

Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding.

Zhang JL, Qiu LY, Kotzsch A, Weidauer S, Patterson L, Hammerschmidt M, Sebald W, Mueller TD.

Dev Cell. 2008 May;14(5):739-50. doi: 10.1016/j.devcel.2008.02.017.

9.

Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4.

Natsume T, Tomita S, Iemura S, Kinto N, Yamaguchi A, Ueno N.

J Biol Chem. 1997 Apr 25;272(17):11535-40.

10.

Crystal structure of recombinant human growth and differentiation factor 5: evidence for interaction of the type I and type II receptor-binding sites.

Schreuder H, Liesum A, Pohl J, Kruse M, Koyama M.

Biochem Biophys Res Commun. 2005 Apr 15;329(3):1076-86.

PMID:
15752764
11.

Variations on ligand-receptor complexes.

Wiesmann C, de Vos AM.

Nat Struct Biol. 2000 Jun;7(6):440-2. No abstract available.

PMID:
10881184
12.
13.

Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.

Hart PJ, Deep S, Taylor AB, Shu Z, Hinck CS, Hinck AP.

Nat Struct Biol. 2002 Mar;9(3):203-8.

PMID:
11850637
14.

Cooperativity of binding epitopes and receptor chains in the BMP/TGFbeta superfamily.

Knaus P, Sebald W.

Biol Chem. 2001 Aug;382(8):1189-95.

PMID:
11592400
15.
16.

A single residue of GDF-5 defines binding specificity to BMP receptor IB.

Nickel J, Kotzsch A, Sebald W, Mueller TD.

J Mol Biol. 2005 Jun 24;349(5):933-47. Epub 2005 Apr 22.

PMID:
15890363
17.

Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction.

Sebald W, Nickel J, Zhang JL, Mueller TD.

Biol Chem. 2004 Aug;385(8):697-710. Review.

PMID:
15449706
18.

Virtual screening and selection of drug-like compounds to block noggin interaction with bone morphogenetic proteins.

Ahmed S, Metpally RP, Sangadala S, Reddy BV.

J Mol Graph Model. 2010 Apr;28(7):670-82. doi: 10.1016/j.jmgm.2010.01.006. Epub 2010 Jan 22.

PMID:
20137990
20.

The 1.1 A crystal structure of human TGF-beta type II receptor ligand binding domain.

Boesen CC, Radaev S, Motyka SA, Patamawenu A, Sun PD.

Structure. 2002 Jul;10(7):913-9.

Supplemental Content

Support Center